💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Illumina, Inc. (ILMN)
« Back to company indexILMN Chatter Timeline
Stock Ticker for ILMN
Most Active Tweeters for ILMN
| User | Tweets |
|---|---|
| @Tickeron | 14 |
| @newsfilterio | 5 |
| @HealthcareBeat | 5 |
| @AmericanBanking | 4 |
| @SdO7 | 4 |
Recent Tweets for ILMN
 |
@MC_OptionTrades $ILMN earnings move -7.0% vs an expected ±7.0% move https://t.co/dW9QtiKs46 7:10pm |
 |
@LoRezTrader @KermitCapital Love seeing those $API adds, bit-by-bit. And it seems like they are on their way out of $ILMN entire… https://t.co/kpCiZxu2Rd 7:10pm |
 |
@Cappin__Crunch RT @bluff_capital: $ILMN Illumina discussing the price paid for the Grail deal vs Exact's Thrive purchase this week, as well as missed canc… 6:10pm |
 |
@bluff_capital $ILMN Illumina discussing the price paid for the Grail deal vs Exact's Thrive purchase this week, as well as missed… https://t.co/rpSMmFGvke 6:10pm |
 |
@QuantchaIdeas Big Loser Alert: Trading today’s -7.1% move in ILLUMINA $ILMN https://t.co/VvPnnK16Lo 12:10pm |
 |
@deus_trader Optimus v4 2020-10-30 10:27 ET. Bought/Opened: $ILMN at $297.54. Illumina, Inc (CORP). Win Chance: 68%. Avg Win: 4… https://t.co/gof5s6Qwr3 10:10am |
 |
@Tickeron $ILMN's 10-day Moving Average moved below its 50-day Moving Average on October 22, 2020. View odds for this and oth… https://t.co/94OFBDtMk8 8:10am |
 |
@Hedgeye RT @HedgeyeHC: We called out $ILMN in our weekly update on Monday and covered earnings in our daily note this morning. Fundamental momentu… 7:10am |
 |
@Quantumup1 BofA~ $ILMN reported an upside 3Q as revenues declined by only -12% (but still below peers) and EPS were ahead of S… https://t.co/QuAhfjJbCI 7:10am |
 |
@HedgeyeHC We called out $ILMN in our weekly update on Monday and covered earnings in our daily note this morning. Fundamenta… https://t.co/d1bXpB6IRq 7:10am |
 |
@jodietheai 5 section(s) of $ILMN 10-Q analyzed; J? score of 2.5/10, 0.0% difference since last filing. 5 redflags found in t… https://t.co/o69JKifseh 6:10am |
 |
@newsfilterio Illumina Reports Financial Results for Third Quarter of Fiscal Year 2020 $ILMN https://t.co/Jjv2YUiiIx 5:10am |
 |
@_B_I_O_T_E_C_H_ Cowen $ILMN Solid Q3 Beat, Encouraging Comments On Momentum Into Q4 & 2021; PT To $350 4:10am |
 |
@Gambiste1 RT @mspacey4415: most interesting part of $ILMN call- before signing the Grail deal they were able to looked at data from the on-going PAT… 3:10am |
 |
@HealthcareBeat Illumina Q3 earnings down 24%; cash flow ops down 43% as grow remains elusive $ILMN https://t.co/iXWbgH2Jt1 2:10am |
|
@newsfilterio Illumina EPS beats by $0.22, beats on revenue $ILMN https://t.co/pk746w9rY2 2:10am |
 |
@mspacey4415 most interesting part of $ILMN call- before signing the Grail deal they were able to looked at data from the on-go… https://t.co/zaVQNeCsbs 1:10am |
 |
@SiteFocusHQ $ILMN Earnings Intelligence Analysis of recent earnings identified Illumina, Inc (ILMN) business focus on (mid-thro… https://t.co/wvxkoOffAi 1:10am |
|
@newsfilterio Illumina Q3 earnings down 24%; cash flow ops down 43% as grow remains elusive $ILMN https://t.co/XAWrnvdR9m 12:10am |
|
@HealthcareBeat Form 425 (prospectuses and communications, business combinations) filed with the SEC $ILMN https://t.co/bxYBRRubxG October 29th 2020, 7:10pm |
 |
@Briefingcom $ILMN: Illumina beats by $0.22, beats on revs https://t.co/hJwK4qLFrM October 29th 2020, 6:10pm |
 |
@communiststocks Illumina - $ILMN ? QUOTE $ILMN was UP ? on Thu Oct 29 Closed at 314.90 USD for a 1.68% gain from previous close ?… https://t.co/mSIfmEQZyT October 29th 2020, 6:10pm |
 |
@FlashAlert_me $ILMN [15s. delayed]: Issued Press Release on October 29, 16:05:00: Illumina Reports Financial Results for Third Qu… https://t.co/EJ3K1nhc46 October 29th 2020, 5:10pm |
 |
@SdO7 @mchaudhry82 $ILMN How they manage to support a 67x PE with no guidance and a massively expensive transforming deal… https://t.co/RP8MCrXM5i October 29th 2020, 5:10pm |
 |
@spottedFirefly $ILMN Illumina EPS beats by $0.22, beats on revenue October 29th 2020, 4:10pm |
 |
@MarketCurrents $ILMN - Illumina Q3 earnings down 24%; cash flow ops down 43% as grow remains elusive https://t.co/1F3JMm1nGy October 29th 2020, 4:10pm |
 |
@dhovekamp42 RT @bradloncar: Pandemic impact on $ILMN revenue. Trying to claw back. https://t.co/Foe7AD6ip7 October 29th 2020, 4:10pm |
 |
@optioncharts $ILMN high OI range is 280.00 to 345.00 for option expiration 10/30/2020 PutCallRatio=1.76 #maxpain #options… https://t.co/cPLjiFqCXK October 29th 2020, 4:10pm |
|
@FlashAlert_me $ILMN [15s. delayed] filed form 8-K on October 29, 16:15:28: Item2.02: Results of Operations & Financial Condition https://t.co/zxyz46ZEZT October 29th 2020, 4:10pm |
 |
@bradloncar Pandemic impact on $ILMN revenue. Trying to claw back. https://t.co/Foe7AD6ip7 October 29th 2020, 4:10pm |
 |
@AccesswireNews $ILMN Illumina, Inc. to Host Earnings Call https://t.co/dEY1swG6xA October 29th 2020, 3:10pm |
 |
@JFDI $ilmn rejectin that low so far October 28th 2020, 12:10pm |
|
@Tickeron $ILMN in Downtrend: Stochastic indicator is sitting in oversold zone for 6 days. View odds for this and other indic… https://t.co/X3Qf65UfIN October 28th 2020, 7:10am |
|
@Tickeron Illumina Inc to report earnings on October 29, 2020. Earnings per share (EPS) estimate: $0.82 $ILMN #Illumina… https://t.co/rFyvjVQPbB October 28th 2020, 5:10am |
 |
@alphagangvestor RT @SeekingAlpha: $ILMN $GRAL - Illumina: Cheap With Further Upside From Grail. https://t.co/cpZ2O8zXXX #economy #finance #stockmarket October 28th 2020, 1:10am |
 |
@SeekingAlpha $ILMN $GRAL - Illumina: Cheap With Further Upside From Grail. https://t.co/cpZ2O8zXXX #economy #finance #stockmarket October 28th 2020, 1:10am |
 |
@Finscreener_com Last Strong #NASDAQ 100 $NDX #large #healthacre #stocks Technical Analysis today: $ILMN https://t.co/CN6r9UWfzA https://t.co/Dgq6xJxkUQ October 27th 2020, 7:10pm |
 |
@sbwcws Cancer screening market big enough for both Illumina, Exact, says Piper Sandler $ILMN $EXAS October 27th 2020, 1:10pm |
|
@bradloncar Maybe $EXAS should buy a few more companies. The exact opposite reaction that $ILMN received when it bought Grail. October 27th 2020, 1:10pm |
|
@HealthcareBeat Exact Sciences Rallies On 2 M&A Deals In Cancer Screening Market $EXAS $ILMN https://t.co/yQlBkoHZPX October 27th 2020, 12:10pm |
|
@newsfilterio Exact Sciences Rallies On 2 M&A Deals In Cancer Screening Market $EXAS $ILMN https://t.co/JHvVcpxn4V October 27th 2020, 12:10pm |
 |
@OptionsMaxPain #Illumina $ILMN Has A Poor #Technical Analysis Score (TA Score). Breakdown Of 3 Categories: #candle score Weak; mov… https://t.co/Hj2srCsHNX October 27th 2020, 10:10am |
 |
@16trippinborys RT @HedgeyeMed: In response to recent $ILMN acquisition of Grail, $EXAS announced the acquisition of Thrive for 2.5B earlier this morning.… October 27th 2020, 8:10am |
 |
@HedgeyeMed In response to recent $ILMN acquisition of Grail, $EXAS announced the acquisition of Thrive for 2.5B earlier this m… https://t.co/EHOEgr7k7s October 27th 2020, 8:10am |
 |
@HedgeyeEEvans The liquid biopsy land rush continues with $EXAS acquisition of Thrive. CMS NCDs de-risking whole approval and coverage process. $ILMN October 27th 2020, 8:10am |
|
@Tickeron $ILMN in Downtrend: Stochastic indicator remains in oversold zone for 5 days. View odds for this and other indicato… https://t.co/QNUyepyqHg October 27th 2020, 7:10am |
|
@SdO7 $ILMN On track to hit $250 by the end of the week. REDUCE! October 26th 2020, 11:10am |
|
@Tickeron $ILMN in Downtrend: Stochastic indicator is staying in oversold zone for 4 days. View odds for this and other indic… https://t.co/iuykmDJKQ1 October 26th 2020, 7:10am |
 |
@AetherPlutus On the 2020-10-20 -> FLATLEY JAY T () sold 3.86M worth of $ILMN stocks #ILMN #SEC #FROM4 #BoardSellingStocks October 25th 2020, 9:10pm |
 |
@MarketChmln $ILMN to report earnings on Oct 29 AMC, with an expected move of ±8.7% https://t.co/s8sHO1gRc1 October 25th 2020, 5:10pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
